Diagnosis of prostate cancer by the combined molecular imaging focused on [18F]choline-PET
| Project/Area Number |
23591793
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Dokkyo Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAJI Yasushi 獨協医科大学, 医学部, 教授 (10273947)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2013: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 前立腺癌 / 画像診断 / ポジトロン断層撮像 / [18F]コリン / MRI |
|---|
| Research Abstract |
As the country's population grows older, increase of prostate cancer is expected in future. We performed PET with the tracer [18F] fluorocholine (FCh) for 71 patients with strong suspicion of having prostate cancer, who were pathologically examined later, and for 8 patients with a suspicion of recurrence. The diagnostic performance of FCh-PET was equivalent to that of MRI, and the diagnosis of the distant metastasis by FCh-PET was almost good.
There was much little number of patients requiring the FCh-PET for searching recurrence than anticipated. So we could hardly perform analysis for diagnostic ability of FCh-PET on the recurrence of prostate cancer during the three year study period, and will continue to get more patients who requires to be diagnosed whether there is recurrence or not. We experienced two cases (out of 79 scans) with unexpected lung cancer incidentally detected by FCh-PET.
|
Report
(4 results)
Research Products
(5 results)
